$2.45 Billion is the total value of Artal Group S.A.'s 110 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 36.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS INC | $334,939,000 | -16.3% | 60,240,864 | 0.0% | 13.68% | -7.7% | |
| WW | WEIGHT WATCHERS INTL INC NEW | $298,589,000 | -47.7% | 14,818,300 | 0.0% | 12.19% | -42.4% | |
| MRNA | Sell | MODERNA INC | $101,878,000 | +26.9% | 5,006,298 | -4.8% | 4.16% | +39.9% |
| BGNE | BEIGENE LTDsponsored adr | $79,200,000 | -5.9% | 600,000 | 0.0% | 3.23% | +3.8% | |
| XLRN | Buy | ACCELERON PHARMA INC | $76,841,000 | +68.0% | 1,650,000 | +57.1% | 3.14% | +85.2% |
| NVDA | New | NVIDIA CORP | $75,415,000 | – | 420,000 | +100.0% | 3.08% | – |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $75,169,000 | +33.1% | 412,000 | 0.0% | 3.07% | +46.7% | |
| CELG | Sell | CELGENE CORPcall | $70,755,000 | +10.4% | 750,000 | -25.0% | 2.89% | +21.7% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $68,043,000 | +110.4% | 850,000 | +41.7% | 2.78% | +131.9% |
| BAC | Sell | BANK AMER CORPcall | $55,180,000 | -50.2% | 2,000,000 | -55.6% | 2.25% | -45.1% |
| RUBY | RUBIUS THERAPEUTICS INC | $52,650,000 | +12.6% | 2,908,791 | 0.0% | 2.15% | +24.1% | |
| ARRY | Sell | ARRAY BIOPHARMA INC | $48,760,000 | +36.9% | 2,000,000 | -20.0% | 1.99% | +50.9% |
| GS | GOLDMAN SACHS GROUP INCcall | $47,998,000 | +14.9% | 250,000 | 0.0% | 1.96% | +26.7% | |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $45,713,000 | +31.6% | 1,150,000 | +15.0% | 1.87% | +45.1% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $44,082,000 | -16.4% | 2,346,040 | +2.2% | 1.80% | -7.8% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $42,053,000 | +15.4% | 450,000 | -10.0% | 1.72% | +27.2% |
| GM | Sell | GENERAL MTRS COcall | $37,100,000 | -68.3% | 1,000,000 | -71.4% | 1.52% | -65.1% |
| GOSS | New | GOSSAMER BIO INC | $35,950,000 | – | 1,658,968 | +100.0% | 1.47% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $35,360,000 | +23.0% | 2,600,000 | -13.3% | 1.44% | +35.7% |
| FATE | Sell | FATE THERAPEUTICS INC | $31,626,000 | +14.6% | 1,800,000 | -16.3% | 1.29% | +26.3% |
| IFRX | Buy | INFLARX NV | $31,177,000 | +71.4% | 825,000 | +65.0% | 1.27% | +88.9% |
| BMY | Buy | BRISTOL MYERS SQUIBB COcall | $31,012,000 | +8.5% | 650,000 | +18.2% | 1.27% | +19.5% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $30,240,000 | +15.0% | 900,000 | +12.5% | 1.24% | +26.8% |
| AGIO | AGIOS PHARMACEUTICALS INC | $26,976,000 | +46.3% | 400,000 | 0.0% | 1.10% | +61.3% | |
| ARGX | Sell | ARGENX SEsponsored adr | $24,968,000 | -3.7% | 200,000 | -25.9% | 1.02% | +6.1% |
| NIO | Sell | NIO INCsponsored ads | $23,460,000 | -34.2% | 4,600,000 | -17.9% | 0.96% | -27.5% |
| EPZM | New | EPIZYME INC | $21,683,000 | – | 1,750,000 | +100.0% | 0.88% | – |
| SAGE | Buy | SAGE THERAPEUTICS INC | $19,881,000 | +107.5% | 125,000 | +25.0% | 0.81% | +128.7% |
| MDCO | Buy | MEDICINES CO | $19,565,000 | +155.6% | 700,000 | +75.0% | 0.80% | +181.3% |
| PRQR | PROQR THRAPEUTICS N V | $19,418,000 | -12.1% | 1,400,000 | 0.0% | 0.79% | -3.1% | |
| NBIX | New | NEUROCRINE BIOSCIENCES INCcall | $17,620,000 | – | 200,000 | +100.0% | 0.72% | – |
| MLCO | Buy | MELCO RESORTS AND ENTMT LTDcall | $16,943,000 | +92.3% | 750,000 | +50.0% | 0.69% | +112.3% |
| ALBO | ALBIREO PHARMA INC | $16,105,000 | +31.3% | 500,000 | 0.0% | 0.66% | +44.9% | |
| AAL | Buy | AMERICAN AIRLS GROUP INCcall | $15,880,000 | +64.8% | 500,000 | +66.7% | 0.65% | +81.5% |
| BLUE | Sell | BLUEBIRD BIO INC | $15,733,000 | -9.4% | 100,000 | -42.9% | 0.64% | -0.2% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $15,608,000 | +22.0% | 400,000 | -33.3% | 0.64% | +34.4% |
| XNCR | XENCOR INC | $15,530,000 | -14.1% | 500,000 | 0.0% | 0.63% | -5.4% | |
| ASND | New | ASCENDIS PHARMA A Ssponsored adr | $14,713,000 | – | 125,000 | +100.0% | 0.60% | – |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $14,346,000 | +155.6% | 979,275 | +86.5% | 0.59% | +181.7% |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCsponsored ads | $14,162,000 | -9.2% | 450,000 | -5.3% | 0.58% | 0.0% |
| KLDO | New | KALEIDO BIOSCIENCES INC | $13,737,000 | – | 947,419 | +100.0% | 0.56% | – |
| AGIO | AGIOS PHARMACEUTICALS INCcall | $13,488,000 | +46.3% | 200,000 | 0.0% | 0.55% | +61.1% | |
| MRTX | New | MIRATI THERAPEUTICS INC | $12,828,000 | – | 175,000 | +100.0% | 0.52% | – |
| ALLO | ALLOGENE THERAPEUTICS INC | $11,564,000 | +7.4% | 400,000 | 0.0% | 0.47% | +18.3% | |
| QCOM | New | QUALCOMM INCcall | $11,406,000 | – | 200,000 | +100.0% | 0.47% | – |
| SLDB | Buy | SOLID BIOSCIENCES INC | $11,040,000 | -17.6% | 1,200,000 | +140.0% | 0.45% | -9.1% |
| ZGNX | ZOGENIX INC | $11,002,000 | +50.9% | 200,000 | 0.0% | 0.45% | +66.3% | |
| FGEN | Sell | FIBROGEN INC | $10,870,000 | -21.7% | 200,000 | -33.3% | 0.44% | -13.6% |
| AXDX | ACCELERATE DIAGNOSTICS INC | $10,510,000 | +82.8% | 500,000 | 0.0% | 0.43% | +101.4% | |
| AMRN | New | AMARIN CORP PLCcall | $10,380,000 | – | 500,000 | +100.0% | 0.42% | – |
| KRYS | Buy | KRYSTAL BIOTECH INC | $9,870,000 | +72.7% | 300,000 | +9.1% | 0.40% | +90.1% |
| RGNX | REGENXBIO INC | $9,743,000 | +36.6% | 170,000 | 0.0% | 0.40% | +50.8% | |
| WVE | New | WAVE LIFE SCIENCES LTD | $9,713,000 | – | 250,000 | +100.0% | 0.40% | – |
| XLRN | ACCELERON PHARMA INCcall | $9,314,000 | +6.9% | 200,000 | 0.0% | 0.38% | +17.6% | |
| DNLI | Sell | DENALI THERAPEUTICS INC | $9,288,000 | -10.1% | 400,000 | -20.0% | 0.38% | -1.0% |
| REPL | Buy | REPLIMUNE GROUP INC | $9,132,000 | +102.9% | 600,000 | +33.3% | 0.37% | +123.4% |
| NIO | Buy | NIO INCcall | $8,925,000 | +40.1% | 1,750,000 | +75.0% | 0.36% | +54.2% |
| VICI | VICI PPTYS INC | $8,752,000 | +16.5% | 400,000 | 0.0% | 0.36% | +28.4% | |
| TCDA | Buy | TRICIDA INC | $8,690,000 | +194.8% | 225,000 | +80.0% | 0.36% | +225.7% |
| TCRR | New | TCR2 THERAPEUTICS INC | $8,541,000 | – | 490,000 | +100.0% | 0.35% | – |
| AGEN | AGENUS INC | $8,168,000 | +24.8% | 2,750,000 | 0.0% | 0.33% | +38.0% | |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $7,968,000 | +102.5% | 600,000 | +20.0% | 0.32% | +122.6% |
| SPRO | SPERO THERAPEUTICS INC | $7,686,000 | +108.3% | 600,000 | 0.0% | 0.31% | +129.2% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $7,016,000 | +18.4% | 400,000 | 0.0% | 0.29% | +30.0% | |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $6,825,000 | +232.9% | 500,000 | +150.0% | 0.28% | +267.1% |
| FOLD | AMICUS THERAPEUTICS INCcall | $6,800,000 | +42.0% | 500,000 | 0.0% | 0.28% | +57.1% | |
| TGTX | Buy | TG THERAPEUTICS INC | $6,432,000 | +292.2% | 800,000 | +100.0% | 0.26% | +331.1% |
| HTHT | New | HUAZHU GROUP LTDsponsored ads | $6,321,000 | – | 150,000 | +100.0% | 0.26% | – |
| TBIO | TRANSLATE BIO INC | $6,114,000 | +35.9% | 600,000 | 0.0% | 0.25% | +49.7% | |
| APLS | New | APELLIS PHARMACEUTICALS INC | $5,850,000 | – | 300,000 | +100.0% | 0.24% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $5,593,000 | – | 50,000 | +100.0% | 0.23% | – |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $5,179,000 | +25.0% | 145,000 | 0.0% | 0.21% | +37.9% | |
| STML | STEMLINE THERAPEUTICS INC | $5,140,000 | +35.3% | 400,000 | 0.0% | 0.21% | +48.9% | |
| ACIU | Buy | AC IMMUNE SA | $5,050,000 | -28.8% | 1,000,000 | +33.3% | 0.21% | -21.7% |
| SWAV | New | SHOCKWAVE MED INC | $5,021,000 | – | 150,000 | +100.0% | 0.20% | – |
| SELB | Buy | SELECTA BIOSCIENCES INC | $4,977,000 | +211.8% | 2,100,000 | +250.0% | 0.20% | +244.1% |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $4,755,000 | +7.5% | 500,000 | 0.0% | 0.19% | +18.3% | |
| ALEC | New | ALECTOR INC | $4,680,000 | – | 250,000 | +100.0% | 0.19% | – |
| CRNX | CRINETICS PHARMACEUTICALS IN | $4,552,000 | -24.1% | 200,000 | 0.0% | 0.19% | -16.2% | |
| MRUS | Buy | MERUS N V | $4,431,000 | +53.5% | 300,000 | +45.5% | 0.18% | +69.2% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $4,384,000 | -44.4% | 35,000 | -50.0% | 0.18% | -38.7% |
| ADRO | ADURO BIOTECH INC | $3,980,000 | +50.8% | 1,000,000 | 0.0% | 0.16% | +66.3% | |
| AKBA | AKEBIA THERAPEUTICS INC | $3,890,000 | +48.1% | 475,000 | 0.0% | 0.16% | +63.9% | |
| SGMO | SANGAMO THERAPEUTICS INC | $3,816,000 | -16.9% | 400,000 | 0.0% | 0.16% | -8.2% | |
| RCUS | ARCUS BIOSCIENCES INC | $3,747,000 | +16.0% | 300,000 | 0.0% | 0.15% | +27.5% | |
| Z | ZILLOW GROUP INCcl c cap stk | $3,474,000 | +10.0% | 100,000 | 0.0% | 0.14% | +21.4% | |
| TWST | TWIST BIOSCIENCE CORP | $3,477,000 | +0.4% | 150,000 | 0.0% | 0.14% | +10.9% | |
| NKTR | Sell | NEKTAR THERAPEUTICScall | $3,360,000 | -48.9% | 100,000 | -50.0% | 0.14% | -43.6% |
| MGTA | MAGENTA THERAPEUTICS INC | $3,294,000 | +188.9% | 200,000 | 0.0% | 0.14% | +221.4% | |
| YI | 111 INCads | $2,921,000 | +5.7% | 450,000 | 0.0% | 0.12% | +16.7% | |
| TORC | RESTORBIO INC | $2,728,000 | -20.9% | 400,000 | 0.0% | 0.11% | -13.3% | |
| DTIL | New | PRECISION BIOSCIENCES INC | $2,693,000 | – | 150,000 | +100.0% | 0.11% | – |
| GRTS | GRITSTONE ONCOLOGY INC | $2,660,000 | -13.9% | 200,000 | 0.0% | 0.11% | -4.4% | |
| AVRO | AVROBIO INC | $2,205,000 | +32.4% | 100,000 | 0.0% | 0.09% | +45.2% | |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $2,150,000 | -5.1% | 200,000 | +33.3% | 0.09% | +4.8% |
| ZFGN | ZAFGEN INC | $1,918,000 | -44.6% | 700,000 | 0.0% | 0.08% | -39.1% | |
| ARAV | New | ARAVIVE INC | $1,804,000 | – | 256,269 | +100.0% | 0.07% | – |
| MGEN | MIRAGEN THERAPEUTICS INC | $1,395,000 | -7.9% | 500,000 | 0.0% | 0.06% | +1.8% | |
| ARPO | AERPIO PHARMACEUTICALS INC | $1,404,000 | -47.0% | 1,558,400 | 0.0% | 0.06% | -41.8% | |
| TIGR | New | UP FINTECH HLDG LTDsponsored ads | $1,294,000 | – | 100,000 | +100.0% | 0.05% | – |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,252,000 | +9.3% | 110,532 | 0.0% | 0.05% | +21.4% | |
| CMRX | Sell | CHIMERIX INC | $1,050,000 | -59.1% | 500,000 | -50.0% | 0.04% | -54.7% |
| NVLNF | NOVELION THERAPEUTICS INC | $315,000 | +46.5% | 256,400 | 0.0% | 0.01% | +62.5% | |
| TRILLIUM THERAPEUTICS INC | $99,000 | -61.5% | 150,000 | 0.0% | 0.00% | -60.0% | ||
| YMAB | Exit | Y MABS THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.04% | – |
| MRNS | Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.05% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.08% | – |
| FIXX | Exit | HOMOLOGY MEDICINES INC | $0 | – | -100,000 | -100.0% | -0.08% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -200,000 | -100.0% | -0.13% | – |
| VALE | Exit | VALE S Acall | $0 | – | -500,000 | -100.0% | -0.24% | – |
| FGEN | Exit | FIBROGEN INCcall | $0 | – | -150,000 | -100.0% | -0.26% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -150,000 | -100.0% | -0.35% | – |
| WYNN | Exit | WYNN RESORTS LTDcall | $0 | – | -100,000 | -100.0% | -0.37% | – |
| BLUE | Exit | BLUEBIRD BIO INCcall | $0 | – | -100,000 | -100.0% | -0.37% | – |
| CMTA | Exit | CLEMENTIA PHARMACEUTICALS IN | $0 | – | -850,000 | -100.0% | -0.37% | – |
| MDCO | Exit | MEDICINES COcall | $0 | – | -600,000 | -100.0% | -0.42% | – |
| MU | Exit | MICRON TECHNOLOGY INCcall | $0 | – | -400,000 | -100.0% | -0.47% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -200,000 | -100.0% | -0.63% | – |
| FCX | Exit | FREEPORT-MCMORAN INCcall | $0 | – | -2,000,000 | -100.0% | -0.76% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -300,000 | -100.0% | -0.81% | – |
| BGNE | Exit | BEIGENE LTDcall | $0 | – | -200,000 | -100.0% | -1.04% | – |
| MS | Exit | MORGAN STANLEYcall | $0 | – | -1,500,000 | -100.0% | -2.20% | – |
| WFC | Exit | WELLS FARGO CO NEWcall | $0 | – | -1,500,000 | -100.0% | -2.56% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.